IMRX
Immuneering Corp
$5.52-0.24 (-4.17%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Immuneering Corp (IMRX) is a publicly traded company with 8 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 7 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 41 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-13 | Neufeld Leah R | CPO | Award | 3,628 | $4.29 | $15,575 | N/A | N/A |
| 2026-02-05 | 2026-02-03 | Bookman Michael | CLO | Award | 176,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-05 | 2026-02-03 | Brakewood Harold Eugene | CBO | Award | 140,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-05 | 2026-02-03 | Hall Brett Matthew | CSO | Award | 344,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-05 | 2026-02-03 | Matushansky Igor | CMO | Award | 140,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-05 | 2026-02-03 | Morales Mallory | CAO | Award | 140,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-05 | 2026-02-03 | Neufeld Leah R | CPO | Award | 140,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-05 | 2026-02-03 | Zeskind Benjamin J. | CEO | Award | 688,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-20 | 2026-01-15 | Schall Thomas J. | Director | Purchase | 21,645 | $4.67 | $101,039 | +14.4% | +5.6% |
| 2026-01-16 | 2026-01-15 | Hall Brett Matthew | CSO | Purchase | 2,298 | $4.57 | $10,502 | +16.9% | +7.9% |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.